Last reviewed · How we verify
Cremin (MOSAPRAMINE)
At a glance
| Generic name | MOSAPRAMINE |
|---|---|
| Drug class | mosapramine |
| Target | D(4) dopamine receptor |
| Modality | Small molecule |
| Therapeutic area | Neuroscience |
| Phase | FDA-approved |
Approved indications
- Schizophrenia
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Cremin CI brief — competitive landscape report
- Cremin updates RSS · CI watch RSS